We consider the design and analysis of two-phase studies of the association between an expensive biomarker and disease progression when phase I data are obtained by pooling registries having different outcome-dependent recruitment schemes. We utilize two analysis methods, namely maximum-likelihood and inverse probability weighting (IPW), to handle missing covariates arising from a two-phase design. In the likelihood framework, we derive a class of residual-dependent designs for phase II sub-sampling from an observed data likelihood accounting for the phase I sampling plans used by the different registries. In the IPW approach, we derive and evaluate optimal stratified designs that approximate Neyman allocation. Simulation studies and an application to a motivating example demonstrate the finite sample improvements from the proposed designs over simple random sampling and standard stratified sampling schemes.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: